Fig. 4: Kaplan-Meier survival curves comparing distinct clusters and ELN2022 and IPSS-M risk classifications in AML (acute myeloid leukemia) and MDS (myelodysplastic syndromes), respectively. | Nature Communications

Fig. 4: Kaplan-Meier survival curves comparing distinct clusters and ELN2022 and IPSS-M risk classifications in AML (acute myeloid leukemia) and MDS (myelodysplastic syndromes), respectively.

From: Network-based clustering unveils interconnected landscapes of genomic and clinical features across myeloid malignancies

Fig. 4

Displayed are the survival probabilities for distinct clusters in AML patients (a) and their survival outcomes stratified by ELN2022 risk classification (b). Corresponding analyses for MDS with survival probabilities across distinct clusters (c) and according to IPSS-M risk classification (d). Groups with fewer than 10 individuals are omitted for clarity.

Back to article page